Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary

References

1. AB Biodisk 2003 Etest Technical Guide no. 4: Antifungal Susceptibility Testing of Yeasts Solna, Sweden: AB Biodisk;
   [Google Scholar]
2. Almirante B., Rodriguez D., Cuenca-Estrella M., Almela M., Sanchez F., Ayats J., Alonso-Tarres C., Rodriguez-Tudela J. L., Pahissa A. 2006; Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 44:1681–1685 [CrossRef]
   [Google Scholar]
3. Barnett J. A., Payne R. W., Yarrow D. 2000; Yeasts . Characteristics and Identification Cambridge, UK: Cambridge University Press;
   [Google Scholar]
4. Bassetti M., Righi E., Costa A., Fasce R., Molinari M. P., Rosso R., Pallavicini F. B., Viscoli C. 2006; Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21 [CrossRef]
   [Google Scholar]
5. Bedini A., Venturelli C., Mussini C., Guaraldi G., Codeluppi M., Borghi V., Rumpianesi F., Barchiesi F., Esposito R. 2006; Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 12:75–80 [CrossRef]
   [Google Scholar]
6. Brito L. R., Guimaraes T., Nucci M., Rosas R. C., Paula Almeida L., Da Matta D. A., Colombo A. L. 2006; Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol 44:261–266
   [Google Scholar]
7. Buntjer J. B. 1997 Phylogenetic Computer Tools ( PhylTools ). Version 1.32 for Windows Wageningen, The Netherlands: Laboratory of Plant Breeding, University of Wageningen;
   [Google Scholar]
8. Cassone A., De Bernardis F., Pontieri E., Carruba G., Girmenia C., Martino P., Fernandez-Rodriguez M., Quindos G., Ponton J. 1995; Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity. J Infect Dis 171:967–975 [CrossRef]
   [Google Scholar]
9. De Hoog G. S., Guarro J., Gene J., Figueras M. J. 2000 Atlas of Clinical Fungi Utrecht: Centraalbureau voor Schimmelcultures;
   [Google Scholar]
10. Dóczi I., Dósa E., Hajdú E., Nagy E. 2002; Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. J Med Microbiol 51:677–681
    [Google Scholar]
11. Enger L., Joly S., Pujol C., Simonson P., Pfaller M., Soll D. R. 2001; Cloning and characterization of a complex DNA fingerprinting probe for Candida parapsilosis . J Clin Microbiol 39:658–669 [CrossRef]
    [Google Scholar]
12. Felsenstein J. 1995 phylip (Phylogeny Inference Package). Version 3.57c. Distributed by the author Seattle: Department of Genetics, University of Washington;
    [Google Scholar]
13. Fundyga R. E., Kuykendall R. J., Lee-Yang W., Lott T. J. 2004; Evidence for aneuploidy and recombination in the human commensal yeast Candida parapsilosis . Infect Genet Evol 4:37–43 [CrossRef]
    [Google Scholar]
14. Iida S., Imai T., Oguri T., Okuzumi K., Yamanka A., Moretti-Branchini M., Nishimura K., Mikami Y. 2005; Genetic diversity of the internal transcribed spacers (ITS) and 5.8 S rRNA genes among clinical isolates of Candida parapsilosis in Brazil and Japan. Jpn J Med Mycol 46:133–137 [CrossRef]
    [Google Scholar]
15. Kimura M. 1980; A simple method for estimating evolutionary rate of base substitutions through comparative studies on nucleotide sequences. J Mol Evol 2:87–90
    [Google Scholar]
16. Kosa P., Valach M., Tomaska L., Wolfe K. H., Nosek J. 2006; Complete DNA sequences of the mitochondrial genomes of the pathogenic yeasts Candida orthopsilosis and Candida metapsilosi s: insight into the evolution of linear DNA genomes from mitochondrial telomere mutants. Nucleic Acids Res 34:2472–2481 [CrossRef]
    [Google Scholar]
17. Kremery V., Barnes A. J. 2002; Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50:243–260 [CrossRef]
    [Google Scholar]
18. Kurtzman C. P., Fell J. W. 1998 The Yeasts, a Taxonomic Study , 4th edn. Amsterdam: Elsevier;
    [Google Scholar]
19. Lehmann P. F., Lin D. M., Lasker B. A. 1992; Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 30:3249–3254
    [Google Scholar]
20. Levy I., Rubin L. G., Vasishtha S., Tucci V., Sood S. E. 1998; Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 26:1086–1088 [CrossRef]
    [Google Scholar]
21. Lin D., Wu L. C., Rinaldi M. G., Lehmann P. F. 1995; Three distinct genotypes within Candida parapsilosis from clinical sources. J Clin Microbiol 33:1815–1821
    [Google Scholar]
22. Lott T. J., Kuykendall R. J., Welbel S. F., Pramanik A., Lasker B. A. 1993; Genomic heterogeneity in the yeast Candida parapsilosis . Curr Genet 23:463–467 [CrossRef]
    [Google Scholar]
23. Lu J. J., Lee S. Y., Chiueh T. S. 2004; In vitro susceptibility testing of Candida blood isolates and evaluation of the E-test method. J Microbiol Immunol Infect 37:335–342
    [Google Scholar]
24. Luo G., Mitchell T. G. 2002; Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol 40:2860–2875 [CrossRef]
    [Google Scholar]
25. Messer S. A., Jones R. N., Fritsche T. R. 2006; International surveillance of Candida spp. and Aspergillus spp. Report from the SENTRY Antimicrobial Surveillance Program (2003 J Clin Microbiol 44:1782–1787 [CrossRef]
    [Google Scholar]
26. National Committee for Clinical Laboratory Standards 2002 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts . Approved standard M27-A2, 2nd edn. Wayne, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
27. Nosek J., Tomaska L., Rycovska A., Fukuhara H. 2002; Mitochondrial telomeres as molecular markers for identification of the opportunistic yeast pathogen Candida parapsilosis . J Clin Microbiol 40:1283–1289 [CrossRef]
    [Google Scholar]
28. Pfaller M. A., Diekema D. J., Jones R. N., Sader H. S., Fluit A. C., Hollis R. J., Messer S. A. SENTRY Participant Group 2001; International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 39:3254–3259 [CrossRef]
    [Google Scholar]
29. Pontieri E., Caracciolo C., Bianchini S., Dantonio D., Novelli G., Dallapiccola B., Carruba G. 2001; Single primer pair for PCR identification of Candida parapsilosis group I isolates. J Med Microbiol 50:441–448
    [Google Scholar]
30. Pryce T. M., Palladino S., Price D. M., Gardam D. J., Campbell P. B., Christiansen K. J., Murray R. J. 2006; Rapid identification of fungal pathogens in BacT/ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions. Diagn Microbiol Infect Dis 54:289–297 [CrossRef]
    [Google Scholar]
31. Rex J. H., Pfaller M. A., Barry A. L., Nelson P. W., Webb C. D. 1995; Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 39:40–44 [CrossRef]
    [Google Scholar]
32. Rodero L., Davel G., Soria M., Vivot W., Cordoba S., Canteros C. E., Saporiti A. 2005; Multicenter study of fungemia due to yeasts in Argentina. Rev Argent Microbiol 37:189–195 in Spanish
    [Google Scholar]
33. Rodriguez D., Almirante B., Park B. J., Cuenca-Estrella M., Planes A. M., Sanchez F., Gene A., Xercavins M., Fontanals D. other authors 2006; Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J 25:224–229 [CrossRef]
    [Google Scholar]
34. Roy B., Meyer S. A. 1998; Confirmation of the distinct genotype groups within the form species Candida parapsilosis . J Clin Microbiol 36:216–218
    [Google Scholar]
35. Rycovska A., Valach M., Tomaska L., Bolotin-Fukuhara M., Nosek J. 2004; Linear versus circular mitochondrial genomes: intraspecies variability of mitochondrial genome architecture in Candida parapsilosis . Microbiology 150:1571–1580 [CrossRef]
    [Google Scholar]
36. Safdar A., Perlin D. S., Armstrong D. 2002; Hematogenous infections due to Candida parapsilosis : changing trends in fungemic patients at a comprehensive cancer center during the last four decades. Diagn Microbiol Infect Dis 44:11–16 [CrossRef]
    [Google Scholar]
37. Saitou N., Nei M. 1987; The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425
    [Google Scholar]
38. Sandven P., Bevanger L., Digranes A., Haukland H. H., Mannsaker T., Gaustad P. 2006; Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol 44:1977–1981 [CrossRef]
    [Google Scholar]
39. San Miguel L. G., Cobo J., Otheo E., Martos I., Muriel A., Fortun J., Moreno S. 2006; Candidemia in pediatric patients with congenital heart disease. Diagn Microbiol Infect Dis 55:203–207 [CrossRef]
    [Google Scholar]
40. Song J. W., Shin J. H., Shint D. H., Jung S. I., Cho D., Kee S. J., Shin M. G., Suh S. P., Ryang D. W. 2005; Differences in biofilm production by three genotypes of Candida parapsilosis from clinical sources. Med Mycol 43:657–661 [CrossRef]
    [Google Scholar]
41. St-Germain G., Laverdiere M., Pelletier R., Bourgault A. M., Libman M., Lemieux C., Noel G. 2001; Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 39:949–953 [CrossRef]
    [Google Scholar]
42. Tavanti A., Davidson A. D., Gow N. A., Maiden M. C., Odds F. C. 2005; Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 43:284–292 [CrossRef]
    [Google Scholar]
43. Thompson J. D., Gibson T. J., Plewniak F., Jeanmougin F., Higgins D. G. 1997; The clustal x windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882 [CrossRef]
    [Google Scholar]
44. Tortorano A. M., Peman J., Benrhardt H., Klingspor L., Kibbler C. C., Faure O., Biraghi E., Canton E., Zimmermann K. other authors 2004; Epidemiology of candidaemia in Europe: results of 28 month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23:317–322 [CrossRef]
    [Google Scholar]
45. Tortorano A. M., Kibbler C., Perman J., Bernhardt H., Klingspor L., Grillot R. 2006; Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359–366 [CrossRef]
    [Google Scholar]
46. Weems J. J. Jr 1992; Candida parapsilosis : epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 14:756–766 [CrossRef]
    [Google Scholar]
47. White T. J., Bruns T. D., Lee S. B., Taylor J. W. 1990; Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In PCR Protocols: a Guide to Methods and Applications pp  315–322 Edited by Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. San Diego, CA: Academic Press;
    [Google Scholar]
48. Williams J. G. K., Kubelik A. R., Livak K. J., Rafalski J. A., Tingey S. V. 1990; DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 18:6531–6535 [CrossRef]
    [Google Scholar]
49. Yapar N., Uysal U., Yucesoy M., Cakir N., Yuce A. 2006; Nosocomial bloodstream infections associated with Candida species in a Turkish university hospital. Mycoses 49:134–138 [CrossRef]
    [Google Scholar]
50. Zeng S., Wu L. C., Lehmann P. F. 1996; Random amplified polymorphic DNA analysis of culture collection strains of Candida species. Med Mycol 34:293–297 [CrossRef]
    [Google Scholar]